Who can use Cerezyme(Imiglucerase)?

Cerezyme (imiglucerase) is a recombinant enzyme replacement therapy primarily indicated for individuals with Gaucher disease, a rare genetic disorder caused by deficient glucocerebrosidase activity. 

Who can use Cerezyme(Imiglucerase)?

It is used across all types of Gaucher disease (Type 1, 2, and 3) to reduce glucocerebroside accumulation in cells, alleviating symptoms like hepatosplenomegaly, anemia, thrombocytopenia, and bone pain.

Eligible users include both pediatric and adult patients diagnosed with Gaucher disease, as determined by clinical and laboratory assessments. The treatment is administered intravenously, with dosing tailored to individual patient needs, often based on body weight and disease severity. It is considered a standard therapy for managing the condition and improving quality of life.